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Vibrio cholerae belonging to serogroups other than O1 and O139 are opportunistic
pathogens which cause infections with a variety of clinical symptoms. Due to the
increasing number of V. cholerae non-O1/non-O139 infections in association with
recreational waters in the past two decades, they have received increasing attention
in recent literature and by public health authorities. Since the treatment of choice
is the administration of antibiotics, we investigated the distribution of antimicrobial
resistance properties in a V. cholerae non-O1/non-O139 population in a large Austrian
lake intensively used for recreation and in epidemiologically linked clinical isolates. In
total, 82 environmental isolates - selected on the basis of comprehensive phylogenetic
information - and nine clinical isolates were analyzed for their phenotypic antimicrobial
susceptibility. The genomes of 46 environmental and eight clinical strains were screened
for known genetic antimicrobial resistance traits in CARD and ResFinder databases.
In general, antimicrobial susceptibility of the investigated V. cholerae population was
high. The environmental strains were susceptible against most of the 16 tested
antibiotics, except sulfonamides (97.5% resistant strains), streptomycin (39% resistant)
and ampicillin (20.7% resistant). Clinical isolates partly showed additional resistance to
amoxicillin-clavulanic acid. Genome analysis showed that crp, a regulator of multidrug
efflux genes, and the bicyclomycin/multidrug efflux system of V. cholerae were present
in all isolates. Nine isolates additionally carried variants of blaCARB−7 and blaCARB−9,
determinants of beta-lactam resistance and six isolates carried catB9, a determinant of
phenicol resistance. Three isolates had both blaCARB−7 and catB9. In 27 isolates, five out
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of six subfamilies of the MATE-family were present. For all isolates no genes conferring
resistance to aminoglycosides, macrolides and sulfonamides were detected. The
apparent lack of either known antimicrobial resistance traits or mobile genetic elements
indicates that in cholera non-epidemic regions of the world, V. cholerae non-O1/non-
O139 play a minor role as a reservoir of resistance in the environment. The discrepancies
between the phenotypic and genome-based antimicrobial resistance assessment show
that for V. cholerae non-O1/non-O139, resistance databases are currently inappropriate
for an assessment of antimicrobial resistance. Continuous collection of both data over
time may solve such discrepancies between genotype and phenotype in the future.
Keywords: Vibrio cholerae, antibiotic resistance, bathing water, climate change, non-O1/non-O139
INTRODUCTION
Antibiotics are supposed to be one of the most effective drugs to
treat infectious diseases transmitted by bacteria (Martinez, 2009).
Nevertheless, antimicrobial resistant bacteria pose one of the
most significant healthcare challenges (WHO, 2017). Emerging
antibiotic resistance is not only restricted to healthcare associated
settings, but also appears in environmental settings, such as
natural aquatic ecosystems (Taylor et al., 2011). The Gram-
negative, potentially pathogenic bacterium Vibrio cholerae is a
natural inhabitant of aquatic environments from freshwater to
seawater. It can thrive in a free floating manner in the water
body (Worden et al., 2006; Kirschner et al., 2008) but it has
also been found on surfaces of crustaceans, algae, plants, and
insects (Colwell, 1996; Halpern et al., 2004; Banerjee et al.,
2014). Currently, more than 200 different serogroups have been
described and only serogroups O1 and O139 are the agents
of epidemic cholera. The remaining non-epidemic serogroups
are therefore referred as V. cholerae non-O1/non-O139. They
are opportunistic pathogens associated with small outbreaks of
diarrheal disease (Deshayes et al., 2015; Hasan et al., 2015; Crowe
et al., 2016). They can also cause severe wound infections and
acute sepsis especially in immunocompromised patients (Sack
et al., 2004; Huhulescu et al., 2007; Hirk et al., 2016; Siriphap
et al., 2017). In recent years, infections due to V. cholerae non-
O1/non-O139 have been increasingly reported for countries of
the Northern hemisphere (Newton et al., 2012; Baker-Austin
et al., 2013), primarily acquired through contact by swimming
in seawater (Baker-Austin et al., 2016b; Marinello et al., 2017)
or freshwater lakes (Dalsgaard et al., 2000a; Ninin et al., 2000;
Andersson and Ekdahl, 2006; Ottaviani et al., 2011; Dobrovic
et al., 2016; Hirk et al., 2016; Kechker et al., 2017). This
significant increase in the number of infections has been linked
to global warming and associated increase in water temperatures
(Baker-Austin et al., 2016a,b; ECDC, 2019). Infections caused
by V. cholerae non-O1/non-O139 have also been reported for
the large subsaline lake Neusiedler See in Austria (Huhulescu
et al., 2007). This lake is part of the largest bird sanctuary in
Central Europe (National Park Neusiedler See - Seewinkel) and
it is intensively used for recreational purposes throughout the
year (swimming, surfing, sailing, fishing etc.). Recently, it was
demonstrated, that the lake harbors an abundant and genetically
diverse endemic V. cholerae community (Schauer et al., 2015;
Pretzer et al., 2017). In the latter study (Pretzer et al., 2017), it was
also shown that many V. cholerae isolates from other European
countries were genetically related to the strains present in the
lake, most probably due to the long distance import of strains (via
birds or humans) from these countries. Thus, the Neusiedler See
may serve as a bioreactor for the appearance of new strains with
new (pathogenic) properties, including antibiotic resistance.
Despite the increasing clinical importance of environmental
V. cholerae, only very limited information is available on
antimicrobial susceptibility of V. cholerae non-O1/non-O139
populations in aquatic ecosystems of the Northern hemisphere
(Aberkane et al., 2015; Bier et al., 2015; Baron et al., 2017).
Drug resistance of V. cholerae is mediated by eﬄux pumps,
by chromosomal mutations and by acquisition of conjugative
plasmids, transposons, integrative and conjugative elements
(ICE) such as SXT elements carrying antibiotic resistance genes
(Kitaoka et al., 2011; Das et al., 2019). Aquatic ecosystems provide
a suitable milieu for spreading antimicrobial resistant traits
through horizontal gene transfer among bacterial populations
(Baquero et al., 2008). Recent publications reported a limited
capacity of V. cholerae non-O1/non-O139 strains to acquire
resistance. Apparently, most of the investigated collections from
Western European waters were susceptible to most antibiotic
tested (Bier et al., 2015; Baron et al., 2017). However, multidrug
resistant V. cholerae have been increasingly reported worldwide,
mainly in clinical O1 and O139 strains (Faruque et al.,
2007; Mandal et al., 2011; Verma et al., 2019), but also in
environmental non-O1/non-O139 isolates in cholera epidemic
areas (Kitaoka et al., 2011). First carbapenemase producing
V. cholerae non-O1/non-O139 strains were recently described
in Western Europe (Aberkane et al., 2015; Bier et al., 2015).
Therefore, monitoring antimicrobial resistance of environmental
populations of V. cholerae non-O1/non-O139 is highly relevant
for public health.
The aim of this study was to determine the phenotypic and
genotypic antimicrobial resistance properties of 91 V. cholerae
non-O1/non-O139 strains (82 representative isolates from
Neusiedler See and 9 Austrian clinical, epidemiologically linked
isolates), by combining in vitro antimicrobial susceptibility
testing and in silico detection of antimicrobial resistance
traits from whole genome sequencing (WGS) data. By this
a comprehensive assessment of the role of the V. cholerae
population in Neusiedler See as a potential reservoir of
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environmental antimicrobial resistance was achieved. Since this
lake may serve as model bioreactor for the appearance of new
pathogenic/resistant Vibrio strains our findings are also relevant
for other subsaline/hyposaline aquatic environments that are
used for recreation.
MATERIALS AND METHODS
Description of the Study Area and Origin
of Isolates
Neusiedler See is a large (320 km2) subsaline, alkaline lake in
Eastern Austria, intensively used for recreational purposes with
several hundred thousand visitors throughout the year. The lake
is located in the temperate climate zone and has experienced
an increase in the average water temperature during the past
30 years of around 1.5◦C (Dokulil et al., 2010). Details on the
lake can be found in earlier publications (Kirschner et al., 2008;
Schauer et al., 2015).
Eighty-two environmental V. cholerae non-O1/non-O139
isolates for the analysis of antibiotic resistance properties
were selected from an existing strain collection consisting of
472 isolates (Pretzer et al., 2017). The majority of these 472
isolates belong to 24 phylogenetic clades, based on multi-locus
sequence analysis (MLSA) (Pretzer et al., 2017). Depending on
the size of the clades (i.e., the number of isolates belonging
to the clades), between one and six representatives of each
clade (n = 46) and additional singletons (n = 36) were
randomly selected, in order to cover the bulk of the genetic
diversity of V. cholerae in the lake (Supplementary Figure S1).
All selected V. cholerae environmental isolates were collected
at Neusiedler See between May 2011 and October 2012
(Supplementary Figure S1).
For comparison, nine V. cholerae non-O1/non-O139 strains
from human infections which had a reported epidemiological
link to Neusiedler See, collected between 2000 and 2015, were
also included in this study (Supplementary Table S1). All of
these strains had been sent to the national reference laboratory
for Vibrio at the Austrian Agency for Health and Food Safety
(AGES). Six of the strains had caused otitis externa, one of them
sepsis, another one prostatitis and for one strain no clinical
symptoms had been reported.
Phenotypic Susceptibility Testing
The susceptibility of the 91 isolates was determined
by disk diffusion method according to the Clinical and
Laboratory Standards Institute (CLSI) guidelines for rapidly
growing pathogens (CLSI, 2018b) including the following
16 antimicrobial agents: ampicillin, amoxicillin-clavulanic
acid, cefotaxime, imipenem, chloramphenicol, nalidixic acid,
ciprofloxacin, norfloxacin, amikacin, gentamicin, streptomycin,
tetracycline, doxycycline, sulfonamides (sulfamethoxazole,
sulfisoxazole, sulfadiazine), trimethoprim-sulfamethoxazole, and
erythromycin. The CLSI interpretative criteria for disk diffusion
susceptibility testing of Vibrio spp. (CLSI, 2015, 2018a) were
used (Supplementary Table S2), except for erythromycin
for which no breakpoint was available. In Baron et al.
(2017), the disc diffusion zones of inhibition of the wild
type population were distributed between 17 and 24 mm.
Therefore, any erythromycin inhibition zone diameter measured
larger or equal to 17 mm was interpreted as susceptible.
Non-susceptible categories (intermediate and resistant) were
interpreted as resistant for this study. The term “multidrug
resistant” was used for isolates being non-susceptible to
at least one agent of three or more different antimicrobial
classes as previously defined by ECDC and CDC experts
(Magiorakos et al., 2012).
Whole-Genome Sequencing and
Antimicrobial Resistance Gene Detection
From the 82 phenotypically tested environmental isolates, 46
isolates were selected for WGS from all but three identified
phylogenetic clades (n = 36) and a few singletons (n = 10), in
order to cover the bulk of the genetic diversity of V. cholerae
in Neusiedler See (Supplementary Figure S1). In addition,
eight of the nine clinical isolates were also sequenced. Bacterial
total DNA was isolated from overnight cultures using the
MagAttract HMW DNA Kit (Qiagen, Hilden, Germany) and
DNA concentration was determined with a Trinean DropSense16
(Unchained Labs, CA, United States). Libraries for WGS were
prepared using the Nextera XT DNA Library Preparation Kit
(Illumina, CA, United States) according to the manufacturer’s
instructions. All isolates were paired-end sequenced using MiSeq
Reagent Kit v3 with a read length of 2 × 300 base pairs
on a MiSeq instrument (Illumina, CA, United States). Velvet
version 1.1.04 (Zerbino and Birney, 2008) was used for de novo
assembly of raw reads and further WGS data interpretation
was carried out in the analysis software SeqSphere + (Ridom,
Münster, Germany).
The presence of antibiotic resistance genes was assessed
with the Comprehensive Antibiotic Resistance Database (CARD)
(Jia et al., 2017) using default settings including “Perfect” and
“Strict” hits only. In addition, the ResFinder database was
used with default settings. Allele libraries for aminoglycosides
(167 targets), macrolides (132 targets) and sulfonamides (49
targets) resistance were downloaded from the ResFinder database
(11/2017) available from the Center for Genomic Epidemiology1
and integrated in the SeqSphere + analysis software. In silico
target scan procedure settings in SeqSphere + for reference
sequences were defined with 90% required identity to reference
sequence and 99% aligned to reference sequence. The following
reference sequences were included: species-specific gene (ompW;
accession no. FJ462451), SXT element integrase gene (int;
AF099172), class 1 integron (intI1; EU436855), dihydrofolate
reductase (dfrA18; AY034138), quinolone resistance protein
(qnrVC1; EU436855), bicyclomycin/multidrug eﬄux system
from V. cholerae O1 biovar El Tor str. N16961 (locus VC1634)
and VcmA, VcmB, VcmD, VcmH, VcmN, VcrM belonging to the
MATE family multidrug eﬄux pumps (Multidrug And Toxic
Compound Extrusion) (Huda et al., 2001, 2003; Begum et al.,
2005; Kuroda and Tsuchiya, 2009).
1http://www.genomicepidemiology.org
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Nucleotide Sequence Accession
Numbers
This Whole Genome Shotgun project has been deposited at
DDBJ/EMBL/GenBank under the accession PRJNA5519292. For
details see Supplementary Table S3. The version described in this
paper is the first version.
RESULTS
Phenotypic Susceptibility
Environmental Isolates
All isolates were susceptible to amoxicillin-clavulanic acid,
cefotaxime, imipenem, chloramphenicol, ciprofloxacin,
norfloxacin, amikacin, gentamicin, tetracycline, trimethoprim,
trimethoprim-sulfamethoxazole (SXT) and erythromycin. All
but one of 82 isolates were resistant to at least one of the
tested antibiotics (Figure 1). Eighty (97.5%) were resistant to
sulfonamides, 54 of them were only detected resistant to this
antibiotic (44%). Twenty-five isolates (30%) were resistant to
sulfonamides and streptomycin, twelve (15%) to sulfonamides
and ampicillin and one isolate (1.1%) was only resistant to
ampicillin. Seven isolates (9%) were multidrug resistant against
sulfonamides, streptomycin and ampicillin.
Clinical Isolates
Overall, antibiotic resistance profiles were very similar in human
and environmental isolates. Resistances against sulfonamides,
streptomycin and ampicillin were the most frequently detected
(Figure 1). The main difference observed was the occurrence
of amoxicillin/clavulanic acid resistance in three clinical isolates.
Three out of the nine isolates were multidrug resistant. None was
pan-susceptible.
2https://www.ncbi.nlm.nih.gov/bioproject/PRJNA551929/
The full detailed list of all isolates tested and the results of
each phenotypic antimicrobial resistance test can be found in the
Supplementary Table S4.
Identification of Antibiotic Resistance
Genes
The coverage obtained for the 54 whole genome
sequenced isolates (46 environmental and eight clinical)
was 68.2-fold and the species-specific gene ompW for
V. cholerae was present in all investigated isolates.
Analysis via CARD identified gene tet(34), an antibiotic
inactivation enzyme and determinant of tetracycline
resistance, and gene CRP, a regulator of multidrug
eﬄux genes, to be present in all 54 investigated isolates
(Supplementary Table S4).
Twelve isolates additionally carried variants of the antibiotic
inactivation enzymes blaCARB−7 (n = 10) or blaCARB−9
(n = 2), determinants of beta-lactam resistance, perfectly
matching the observed phenotypic resistance against the beta-
lactam antibiotic ampicillin. Six isolates additionally carried
the inactivation enzyme catB9, a determinant of phenicol
resistance, despite the fact that no chloramphenicol resistance
was observed for these isolates. Three isolates carried both
blaCARB−7 and catB9. For all 54 isolates, no genes conferring
resistance to aminoglycosides, macrolides nor sulfonamides were
detected. The integron 1 integrase gene intI1, the two SXT
integron-related resistance factors dfrA18, qnrVC1 and diverse
SXT elements were absent in all investigated isolates. The
bicyclomycin/multidrug eﬄux system locus of V. cholerae strain
VC1634, which is involved in sulfonamide and bicyclomycin
resistance, was present in all isolates. In 27 of 54 isolates five
(VcmA, VcmB, VcmD, VcmH, VcrM) out of six subfamilies of
the MATE (Multidrug and toxic compound extrusion)-family
were present (Table 1 and Supplementary Table S4). VcmN
was never detected.
FIGURE 1 | Percentage of phenotypic antibiotic resistance of 82 environmental and nine clinical isolates. SUL (sulfonamides), STR (streptomycin), AMP (ampicillin),
NAL (nalidixic acid), AMO/CLA (amoxicillin-clavulanic acid).
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TABLE 1 | Phenotypic and genotypic resistance profiles of the 54 whole genome sequenced V. cholerae isolates.
Source Phenotypic resistance Number of tet(34) catB9 blaCARB−7 blaCARB−9 Bicyclomycin/multidrug MATE multidrug CRP
profile isolates efflux system efflux pump
Environmental SUL 1 + + − − + + +
(n = 46) 17 + − − − + + +
SUL, AMP 4 + − + − + + +
2 + − − + + + +
SUL, STR 4 + + − − + + +
15 + − − − + + +
SUL, AMP, STR 1 + + + − + + +
2 + − + − + + +
Clinical (n = 8) STR 2 + − − − + + +
STR, SUL 1 + − − − + + +
1 + + − − + + +
STR, AMO/CLA 1 + − − − + + +
STR, AMP, SUL 1 + + + − + + +
STR, AMP, SUL, AMO/CLA 1 + + + − + + +
1 + − + − + + +
Phenotypic resistance was determined according to CLSI breakpoints (CLSI, 2015, 2018b): SUL: sulfonamides, AMP: ampicillin, STR: streptomycin; AMO/CLA:
amoxicillin/clavulanic acid; the presence of antibiotic resistance genes was extracted from WGS data: ± = gene or mutation was present/absent. Only resistance
targets with at least one positive isolate are shown.
DISCUSSION
All Strains Are Susceptible to First-Line
Treatment Options and Carbapenems
All environmental and clinical isolates were susceptible to
ciprofloxacin, norfloxacin, doxycycline and extended spectrum
cephalosporins, the recommended treatment options for
V. cholerae non-O1/non-O139 infections (Daniels and Shafaie,
2000). Thus, a loss of effectiveness of first-line treatments
for V. cholerae infections related to Neusiedler See is not
observed so far. Moreover, in agreement with the susceptibility
to extended spectrum cephalosporins and carbapenems, no
extended spectrum β-lactamase or carbapenemase genes were
identified. Carbapenemase genes in Vibrio cholerae non-O1/non-
O139 populations are uncommon in Europe, carbapenemase
genes were so far only found in avian swab samples in France
(Aberkane et al., 2015), a United Kingdom patient flying back
from India (Darley et al., 2012) and the presence of undefined
carbapenemases was reported for four Baltic Sea isolates
(Bier et al., 2015).
Wide-Spread Resistance Against “Old
Antibiotics”
Among the 82 environmental isolates, phenotypic resistances
were only observed against the “old antibiotics” such as
sulfonamides, streptomycin and ampicillin which had been
widely used before the 1970’s, 9% of the isolates were multidrug
resistant. Widespread resistance of V. cholerae non-O1/non-
O139 strains against these substances has also been observed in
wastewater and cockles of a Western European estuary (Baron
et al., 2017). In other aquatic ecosystems from cholera free
regions of the temperate climate zone, resistance to streptomycin
and ampicillin was reported as well in the Baltic Sea and
the North Sea (Bier et al., 2015) and the Chesapeake Bay
(Ceccarelli et al., 2015). However, resistance to sulfonamides
alone was not tested in those studies but only in combination with
trimethoprim. Overall, the percentage of resistance against these
three antibiotics was higher in Neusiedler See in comparison
to the other investigations. In our study, 98% of the strains
were resistant to sulfonamides, while in the Western European
estuary it was 45%. Concerning ampicillin, 24% of our isolates
showed resistance in comparison to 9% (Baron et al., 2017), 10%
(Bier et al., 2015) and 7% (Ceccarelli et al., 2015); concerning
streptomycin it was 39% resistant isolates from Neusiedler See
in comparison to 22% (Baron et al., 2017), 25% (Bier et al.,
2015) and 8% (Ceccarelli et al., 2015). The high rates of acquired
resistances against sulfonamides and streptomycin in the isolates
of Neusiedler See indicate a continuous selective pressure from
these antibiotic classes. So far, there is no evidence showing
the presence of those antibiotics in the lake triggering such
resistance and monitoring of these antibiotics in the lake would
be necessary. Currently, the presence of antibiotics in water
by constant monitoring is not regulated in Austria and other
European countries, which makes it difficult to assess the actual
cause for the observed antibiotic resistance of V. cholerae non-
O1/non-O139 strains (Inreiter et al., 2016). Streptomycin is
widely used in plant agriculture, predominantly for combating
fire blight and it has been permitted on an emergency use basis,
subject to annual review and under tightly restricted conditions,
in Austria (Stockwell and Duffy, 2012). High acquired resistance
rates to sulfonamides have been observed in V. cholerae O1
(Eibach et al., 2016) but investigations on V. cholerae non-
O1/non-O139 are rare. Concerning resistance to beta-lactams,
the first strain of V. cholerae with acquired resistance to ampicillin
due to a plasmid located beta-lactamase has been detected in
1977 (Hedges et al., 1977). From the 1990s onward several
studies describe the prevalence of ampicillin resistance observed
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in environmental strains of V. cholerae non-O1/non-O139 in
different parts of the world (Choury et al., 1999; Dalsgaard
et al., 2000b; Melano et al., 2002; Petroni et al., 2004). The
ampicillin resistance genes are carried by class 1 integrons.
At least three carbenicillin-hydrolyzing beta-lactamases (CARB-
6, CARB-7, and CARB-9) have been described in V. cholerae
(Choury et al., 1999; Melano et al., 2002; Petroni et al., 2004).
In our study, twenty ampicillin resistant environmental isolates
were identified. From the nine sequenced isolates, a perfect
match between the presence beta-lactamase genes and ampicillin
resistance phenotype was observed.
The clinical isolates showed similar resistance patterns as
the environmental isolates. However, three of them (33%) were
additionally resistant to the combination of amoxicillin and
clavulanic acid. No such resistance was found for patient and
environmental isolates from the North and Baltic Sea region (Bier
et al., 2015), but 19 of 42 environmental isolates from the Adriatic
Sea (45%) and 3 of 9 Italian clinical isolates (33%) were resistant
to the combination of penicillins and beta-lactamase inhibitors
(Ottaviani et al., 2018). Nevertheless, prudent interpretation of
the present data is required, as the three strains categorized as
resistant to amoxicillin – clavulanic acid, displayed an inhibition
zone diameter just below the susceptibility breakpoint. This
breakpoint is supposed to be used “for Vibrio spp. other than
V. cholerae” (CLSI, 2015). Due to limitations of the method, it
can be hypothesized that these three strains have probably been
falsely categorized as resistant.
Divergent Phenotypic and Genotypic
Antimicrobial Profiles
Several divergent phenotypic and genotypic antimicrobial
findings were obtained. All sequenced isolates harbored the
tet(34) gene, encoding for a tetracycline inactivation enzyme
(Nonaka and Suzuki, 2002), while all isolates were susceptible
to tetracyclines. It should be noticed that the tet(34) gene
was originally cloned from a Vibrio spp. and oxytetracycline
resistance was only expressed in presence of MgCl2 (Nonaka
and Suzuki, 2002). It is possible that under in vitro conditions
of our susceptibility tests, gene tet(34) was not expressed.
Moreover, to date the clinical relevance of gene tet(34) is still
unknown (Grossman, 2016). In six out of 46 environmental
and three out of eight fully sequenced clinical isolates, the
catB9 gene was present. This gene, a chromosome-encoded
variant of the cat gene found in V. cholerae encodes for
a chloramphenicol acetyltransferase and confers resistance to
chloramphenicol (Rowe-Magnus et al., 2002). In contrast, none
of the isolates was resistant to chloramphenicol. No gene
conferring sulfonamide resistance (e.g., sul2) and streptomycin
(e.g., strB) for V. cholerae was found using either CARD or
ResFinder databases, although nearly all of our strains were
tested phenotypically resistant to these two antibiotics. These
findings indicate that current databases are partly incomplete
for assessing antimicrobial resistance properties of V. cholerae
non-O1/non-O139 strains on genotypic characterization alone.
Despite the fact that WGS allows detection of a much higher
number of resistance markers, the clinical relevance of most of
them still needs to be determined. Clinicians should thus still
rely on phenotypic characterization of antimicrobial resistance
properties of V. cholerae strains instead of depending on in silico
assessment alone (Nahar and Bin Rashid, 2017). Vice-versa, when
a resistance mechanism is detected in the genome, while the
isolate is phenotypically susceptible, the interpretation criteria of
the antibiogram may also be questioned. In fact, the literature
comparing phenotypic and genotypic antimicrobial resistance in
V. cholerae non-O1/non-O139 is still poor compared to either
E. coli, K. pneumoniae or S. aureus. Continuous collection of both
data over time may solve such discrepancies between genotype
and phenotype in the future.
Both Clinical and Environmental Isolates
Do Not Harbor Integrons
Despite the fact that V. cholerae is a highly diverse species
that is able to easily take up extracellular DNA (Matthey and
Blokesch, 2016), no common integrons and other integrative
and conjugative elements able to carry antimicrobial resistance
determinants have been identified. All sequenced clinical and
environmental strains were negative for SXT elements or class
I integron. This finding is in agreement with the other studies
(Bier et al., 2015; Ceccarelli et al., 2015; Baron et al., 2017) and
suggests that in non-cholera epidemic regions, the dissemination
of antibiotic resistance genes via mobile genetic elements through
V. cholerae colonization of the aquatic environment is probably of
very limited impact.
Ampicillin Resistance Is Concentrated in
Specific Phylogenetic Lineages
Finally, we tried to elucidate whether the observed phenotypic
and genotypic profiles of the environmental strains were reflected
by their phylogeny (see Supplementary Figure S1; Pretzer et al.,
2017). Only two resistance traits were suitable for such inter-
comparison - ampicillin resistance (n = 20) and the presence of
the catB9 gene (n = 6), as all other traits were too abundant.
From the identified 150 sequence types (STs) (Pretzer et al.,
2017), the 20 ampicillin resistant isolates belonged to 15 different
STs with eleven of the isolates belonging to only two out of 24
identified phylogenetic clades (Supplementary Table S5). Four
isolates belonged to ST 75 (clade III) and three to ST 59 (clade I).
In addition, one ST 62 and one ST 65 isolate clustered with ST 75
isolates in clade III and one ST 64 and one ST 76 isolate clustered
with ST 59 isolates in clade I. These data show that ampicillin
resistance, and consequently the CARB-7 and CARB-9 encoding
genes are present only in specific phylogenetic lineages and not
evenly distributed among the V. cholerae population in the lake.
No such phylogenic relationship was observed for the catB9 gene.
CONCLUSION
The large Austrian lake Neusiedler See is an important bathing
water with several hundred thousand visitors each year. As
it is harboring an abundant and diverse natural V. cholerae
non-O1/non-O139 community associated with several cases of
human infection each year, the comprehensive assessment of
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the antimicrobial resistance properties of this pathogen is of
public health concern. For this purpose, we combined phenotypic
antibiotic susceptibility tests with genotypic characterization of
environmental and clinical whole-genome-sequenced isolates,
covering most of phylogenetic V. cholerae diversity in the lake.
The specific model characteristics of the lake as a bioreactor for
the appearance of new pathogenic/resistant Vibrio strains render
our findings relevant also for other subsaline/hyposaline aquatic
environments that are used for recreational purposes.
Our results clearly showed that all isolates were susceptible
to all important first-line and last-line treatment options.
Widespread resistance was only observed against old antibiotics
such as sulfonamides, streptomycin and ampicillin. The apparent
lack of either known antimicrobial resistance traits or mobile
genetic elements indicates that in cholera non-epidemic regions
of the world, V. cholerae non-O1/non-O139 play only a minor
role as reservoir of antibiotic resistance genes. Nonetheless, the
observed discrepancies between the phenotypic and genotypic
resistance data highlight the need for improvement of the
resistance databases for V. cholerae non-O1/non-O139 to better
understand how these pathogens acquire and disseminate
resistance traits in the aquatic environment.
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